LETTER TO THE EDITOR
Dual liver metastases from advanced genital extramammary Paget's disease and sigmoid cancer: Gathering each disease status from serum cytokeratin 19 fragment and carcinoembryonic antigen
Himino Ashida,
Corresponding Author
Himino Ashida
Department of Dermatology, Okayama Medical Center, Okayama, Japan
Correspondence
Himino Ashida, Department of Dermatology, Okayama Medical Center, 1711-1 Tamasu, Kita-ku, Okayama 701-1192, Japan.
Email: [email protected]
Search for more papers by this author Keiko Manabe,
Keiko Manabe
Department of Dermatology, Okayama Medical Center, Okayama, Japan
Department of Dermatology, Takamatsu Red Cross Hospital, Takamatsu, Japan
Search for more papers by this author Toshiyuki Wakatsuki,
Toshiyuki Wakatsuki
Department of Gastroenterological Medicine, Okayama Medical Center, Okayama, Japan
Search for more papers by this author Yoko Shinno,
Yoko Shinno
Department of Pathology, Okayama Medical Center, Okayama, Japan
Search for more papers by this author Shin'ichi Shimizu,
Shin'ichi Shimizu
Department of Gastroenterological Medicine, Okayama Medical Center, Okayama, Japan
Search for more papers by this author Kenji Asagoe,
Kenji Asagoe
Department of Dermatology, Okayama Medical Center, Okayama, Japan
Search for more papers by this author
Himino Ashida,
Corresponding Author
Himino Ashida
Department of Dermatology, Okayama Medical Center, Okayama, Japan
Correspondence
Himino Ashida, Department of Dermatology, Okayama Medical Center, 1711-1 Tamasu, Kita-ku, Okayama 701-1192, Japan.
Email: [email protected]
Search for more papers by this author Keiko Manabe,
Keiko Manabe
Department of Dermatology, Okayama Medical Center, Okayama, Japan
Department of Dermatology, Takamatsu Red Cross Hospital, Takamatsu, Japan
Search for more papers by this author Toshiyuki Wakatsuki,
Toshiyuki Wakatsuki
Department of Gastroenterological Medicine, Okayama Medical Center, Okayama, Japan
Search for more papers by this author Yoko Shinno,
Yoko Shinno
Department of Pathology, Okayama Medical Center, Okayama, Japan
Search for more papers by this author Shin'ichi Shimizu,
Shin'ichi Shimizu
Department of Gastroenterological Medicine, Okayama Medical Center, Okayama, Japan
Search for more papers by this author Kenji Asagoe,
Kenji Asagoe
Department of Dermatology, Okayama Medical Center, Okayama, Japan
Search for more papers by this author
First published: 05 February 2023
No abstract is available for this article.
REFERENCES
- 1Kato J, Sumikawa Y, Hida T, Kamiya T, Horimoto K, Kamiya S, et al. Serum cytokeratin 19 fragment 21-1 is a useful tumor marker for the assessment of extramammary Paget's disease. J Dermatol. 2017; 44: 666–70.
- 2Kato H, Nakamura M, Watanabe S, Oda T, Morita A. Combined serum carcinoembryonic antigen and cytokeratin 19 fragment levels provide a sensitive biomarker for lymph node metastasis in extramammary Paget's disease. J Dermatol. 2020; 47: 763–9.
- 3Umemura H, Yamasaki O, Kaji T, Otsuka M, Asagoe K, Iwatsuki K. Serum carcinoembryonic antigen level as a marker for advanced stage and chemotherapeutic response in extramammary Paget's disease. Acta Derm Venereol. 2018; 98: 706–7.
- 4Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, et al. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease. Br J Dermatol. 2009; 161: 577–82.
- 5Onishi M, Maeda F, Akasaka T, Amano H. Monitoring serum cytokeratin 19 fragment 21-1 to determine the efficacy of docetaxel chemotherapy in advanced extramammary Paget's disease. J Dermatol. 2019; 46: e83–4.
